Biliary atresia (BA) is a devastating cholestatic liver disease targeting infants. Current
diagnosis depends on surgical exploration of the biliary tree. The aim of the present study …

Objective: There is an urgent need to identify noninvasive and convenient biomarkers for
early diagnosis of biliary atresia (BA). The aim of the present study was to identify potential …

Early diagnosis of biliary atresia (BA) is crucial for improving the chances of survival and
preserving the liver function of pediatric patients with BA. Herein, we performed proteomics …

Biliary atresia (BA) is a destructive inflammatory obliterative cholangiopathy of the neonate
that affects various parts of the bile duct. If early diagnosis followed by Kasai …

Biliary atresia (BA) is a severe chronic cholestasis disorder of infants that leads to death if
not treated on time. Neonatal hepatitis syndrome (NHS) is another leading cause of …

Early diagnosis and timely surgical Kasai portoenterostomy greatly improve the survival of
patients with biliary atresia (BA), a neonatal cholestatic disease, which has encouraged …

Biliary atresia (BA) is a rare neonatal cholestatic disorder caused by obstruction of extra-and
intra-hepatic bile ducts. If untreated, progressive liver cirrhosis will lead to death within 2 …

Background: Biliary atresia (BA) is the most serious liver disease in infants. Diagnosis
currently depends on surgical exploration of the biliary tree. Noninvasive tests that …

The clinical diagnosis of biliary atresia (BA) poses challenges, particularly in distinguishing it
from cholestasis (CS). Moreover, the prognosis for BA is unfavorable and there is a dearth of …

The aim of this review is to specify new potential reliable and non-invasive methods for the
diagnosis of biliary atresia (BA) that could shorten the way to diagnose BA, and finally the …